A. Drug classification based on chemical structure and MOA
B. Major structural features in determing drug potency and pharmaceutical properties
C. MOA of representative drugs
D. History of drug development
a. Adrenergic blockers
b. HMG-CoA reductase inhibitors
c. Cholesterol absorption inhibitors-Ezetimibe
d. Direct thrombin inhibitors
E. Drug names that may be tested in the exam
Digitoxin
Digoxin
Lanatoside
Amyl nitrite
Glyceroltrinitrate
Isosorbide dinitrate
Erythrityl tetranitrate
Pentaerythritol tetranitrate
Quinidine
Lidocaine
Flecainide
Propranolol
Bretylium tasylate
Aminodarone
Nifedioine
Isradipine
PN202.791
Isoprenaline
Penbutolol
Acebutolol
Atenolol
Labetalol
Prazosin
Methyldopa
Clonidine
Methyrosine
Reserpine
Hydralazine
Sodium nitroprusside
Sildenafil
Minoxidil
Diazoxide
Mevastatin
Lovastatin
Ezetimibe
Squalestatin
Nicotine acid
Gemfibrazil
Coumarin
Vitamin K
Warfarin
Brodifacoum
1,3-indandione
Heparin
Fondarinux
Idraparinux
Hirudin
Bivlirudin
A. Drug classification based on chemical structure and MOA
B. Major structural features in determing drug potency and pharmaceutical properties
C. MOA of representative drugs
D. History of drug development
a. Adrenergic blockers
b. HMG-CoA reductase inhibitors
c. Cholesterol absorption inhibitors-Ezetimibe
d. Direct thrombin inhibitors
E. Drug names that may be tested in the exam
Digitoxin
Digoxin
Lanatoside
Amyl nitrite
Glyceroltrinitrate
Isosorbide dinitrate
Erythrityl tetranitrate
Pentaerythritol tetranitrate
Quinidine
Lidocaine
Flecainide
Propranolol
Bretylium tasylate
Aminodarone
Nifedioine
Isradipine
PN202.791
Isoprenaline
Penbutolol
Acebutolol
Atenolol
Labetalol
Prazosin
Methyldopa
Clonidine
Methyrosine
Reserpine
Hydralazine
Sodium nitroprusside
Sildenafil
Minoxidil
Diazoxide
Mevastatin
Lovastatin
Ezetimibe
Squalestatin
Nicotine acid
Gemfibrazil
Coumarin
Vitamin K
Warfarin
Brodifacoum
1,3-indandione
Heparin
Fondarinux
Idraparinux
Hirudin
Bivlirudin